Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, Nuffield Orthopaedic Centre, University of Oxford, Oxford, UK.
Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Southmead Hospital, Bristol, UK.
Health Technol Assess. 2021 Nov;25(66):1-126. doi: 10.3310/hta25660.
Although routine NHS data potentially include all patients, confounding limits their use for causal inference. Methods to minimise confounding in observational studies of implantable devices are required to enable the evaluation of patients with severe systemic morbidity who are excluded from many randomised controlled trials.
Stage 1 - replicate the Total or Partial Knee Arthroplasty Trial (TOPKAT), a surgical randomised controlled trial comparing unicompartmental knee replacement with total knee replacement using propensity score and instrumental variable methods. Stage 2 - compare the risk benefits and cost-effectiveness of unicompartmental knee replacement with total knee replacement surgery in patients with severe systemic morbidity who would have been ineligible for TOPKAT using the validated methods from stage 1.
This was a cohort study.
Data were obtained from the National Joint Registry database and linked to hospital inpatient (Hospital Episode Statistics) and patient-reported outcome data.
Stage 1 - people undergoing unicompartmental knee replacement surgery or total knee replacement surgery who met the TOPKAT eligibility criteria. Stage 2 - participants with an American Society of Anesthesiologists grade of ≥ 3.
The patients were exposed to either unicompartmental knee replacement surgery or total knee replacement surgery.
The primary outcome measure was the postoperative Oxford Knee Score. The secondary outcome measures were 90-day postoperative complications (venous thromboembolism, myocardial infarction and prosthetic joint infection) and 5-year revision risk and mortality. The main outcome measures for the health economic analysis were health-related quality of life (EuroQol-5 Dimensions) and NHS hospital costs.
In stage 1, propensity score stratification and inverse probability weighting replicated the results of TOPKAT. Propensity score adjustment, propensity score matching and instrumental variables did not. Stage 2 included 2256 unicompartmental knee replacement patients and 57,682 total knee replacement patients who had severe comorbidities, of whom 145 and 23,344 had linked Oxford Knee Scores, respectively. A statistically significant but clinically irrelevant difference favouring unicompartmental knee replacement was observed, with a mean postoperative Oxford Knee Score difference of < 2 points using propensity score stratification; no significant difference was observed using inverse probability weighting. Unicompartmental knee replacement more than halved the risk of venous thromboembolism [relative risk 0.33 (95% confidence interval 0.15 to 0.74) using propensity score stratification; relative risk 0.39 (95% confidence interval 0.16 to 0.96) using inverse probability weighting]. Unicompartmental knee replacement was not associated with myocardial infarction or prosthetic joint infection using either method. In the long term, unicompartmental knee replacement had double the revision risk of total knee replacement [hazard ratio 2.70 (95% confidence interval 2.15 to 3.38) using propensity score stratification; hazard ratio 2.60 (95% confidence interval 1.94 to 3.47) using inverse probability weighting], but half of the mortality [hazard ratio 0.52 (95% confidence interval 0.36 to 0.74) using propensity score stratification; insignificant effect using inverse probability weighting]. Unicompartmental knee replacement had lower costs and higher quality-adjusted life-year gains than total knee replacement for stage 2 participants.
Although some propensity score methods successfully replicated TOPKAT, unresolved confounding may have affected stage 2. Missing Oxford Knee Scores may have led to information bias.
Propensity score stratification and inverse probability weighting successfully replicated TOPKAT, implying that some (but not all) propensity score methods can be used to evaluate surgical innovations and implantable medical devices using routine NHS data. Unicompartmental knee replacement was safer and more cost-effective than total knee replacement for patients with severe comorbidity and should be considered the first option for suitable patients.
Further research is required to understand the performance of propensity score methods for evaluating surgical innovations and implantable devices.
This trial is registered as EUPAS17435.
This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in ; Vol. 25, No. 66. See the NIHR Journals Library website for further project information.
尽管常规国民保健制度数据可能包含所有患者,但混杂因素限制了其在因果推断中的使用。需要使用最小化混杂的方法来观察性研究植入式设备,以便评估被许多随机对照试验排除在外的严重系统性疾病患者。
第 1 阶段——复制全膝关节或部分膝关节置换术试验(TOPKAT),这是一项比较单髁膝关节置换术与全膝关节置换术的手术随机对照试验,使用倾向评分和工具变量方法。第 2 阶段——使用第 1 阶段验证的方法,比较严重系统性疾病患者中接受单髁膝关节置换术与全膝关节置换术的风险效益和成本效益。
这是一项队列研究。
数据来自全国关节登记数据库,并与医院住院(医院发病统计)和患者报告的结果数据相关联。
第 1 阶段——符合 TOPKAT 入选标准的接受单髁膝关节置换术或全膝关节置换术的患者。第 2 阶段——美国麻醉医师协会(ASA)分级≥3 级的患者。
患者接受单髁膝关节置换术或全膝关节置换术。
主要观察指标为术后牛津膝关节评分。次要观察指标为术后 90 天并发症(静脉血栓栓塞、心肌梗死和人工关节感染)和 5 年翻修风险和死亡率。健康经济学分析的主要观察指标为健康相关生活质量(EuroQol-5 维度)和国民保健制度医院成本。
第 1 阶段,倾向评分分层和逆概率加权复制了 TOPKAT 的结果。倾向评分调整、倾向评分匹配和工具变量没有。第 2 阶段包括 2256 例单髁膝关节置换患者和 57682 例全膝关节置换患者,他们有严重的合并症,其中 145 例和 23344 例有相关联的牛津膝关节评分。倾向评分分层显示单髁膝关节置换术有统计学意义但临床意义不大的优势,术后牛津膝关节评分差异小于 2 分;逆概率加权无显著差异。与全膝关节置换术相比,单髁膝关节置换术显著降低静脉血栓栓塞的风险[相对风险 0.33(95%置信区间 0.15 至 0.74),倾向评分分层;相对风险 0.39(95%置信区间 0.16 至 0.96),逆概率加权]。使用任何方法,单髁膝关节置换术与心肌梗死或人工关节感染均无相关性。长期来看,单髁膝关节置换术的翻修风险是全膝关节置换术的两倍[风险比 2.70(95%置信区间 2.15 至 3.38),倾向评分分层;风险比 2.60(95%置信区间 1.94 至 3.47),逆概率加权],但死亡率减半[风险比 0.52(95%置信区间 0.36 至 0.74),倾向评分分层;逆概率加权无显著影响]。对于第 2 阶段的参与者,单髁膝关节置换术的成本较低,质量调整生命年获益较高。
尽管一些倾向评分方法成功地复制了 TOPKAT,但未解决的混杂因素可能影响了第 2 阶段。缺失的牛津膝关节评分可能导致信息偏倚。
倾向评分分层和逆概率加权成功复制了 TOPKAT,这意味着一些(但不是全部)倾向评分方法可以用于使用常规国民保健制度数据评估手术创新和植入式医疗器械。对于严重合并症患者,单髁膝关节置换术比全膝关节置换术更安全、更具成本效益,应成为合适患者的首选方案。
需要进一步研究以了解用于评估手术创新和植入式设备的倾向评分方法的性能。
本试验由英国国家卫生与保健研究院(NIHR)卫生技术评估计划资助,并将在;第 25 卷,第 66 期。有关该项目的更多信息,请访问 NIHR 期刊库网站。